Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px
Document › Details

Boehringer Ingelheim. (4/14/10). "Press Release: Boehringer Ingelheim Announces Successful Completion of a Tender Offer to Acquire Outsstanding Shares in SSP Co., Ltd.". Ingelheim.

Organisations Organisation SS Pharmaceutical Co., Ltd. (SS Seiyaku)
  Today SSP Co., Ltd.
  Group Boehringer Ingelheim (Group)
  Organisation 2 Nippon Boehringer Ingelheim Co., Ltd.
  Group Boehringer Ingelheim (Group)
Products Product pharmaceutical
  Product 2 DRUGS–OTC
     


Boehringer Ingelheim announced today that Boehringer Ingelheim Japan Investment GK ("BIJI") successfully completed its tender offer to acquire common stocks of SSP Co., Ltd. ("SSP"). The offer period expired on 13. April 2010 and a total of 93.8 % of outstanding SSP shares were tendered and accepted at JPY 710 per share. Total consideration for the offer is approximately JPY 77.2 billion (approx 611 Mio. €).

BIJI is a wholly-owned subsidiary of Boehringer Ingelheim Auslandsbeteiligungs GmbH ("BIAB"), a management company of the majority of the overseas Boehringer Ingelheim group of companies. Nippon Boehringer Ingelheim Co., Ltd., which is also a wholly-owned Japanese subsidiary of BIAB and a former parent of SSP, tendered all its SSP shares (approximately 60.2% of the issued shares) in the offer.

For further information, please visit our press release (in Japanese)After the completion of the offer, BIJI intends to request that SSP take series of procedures necessary under the Japanese law to make SSP a wholly-owned subsidiary of BIJI.

Contacts:
Tetsuya Owari
Nippon Boehringer Ingelheim Co., Ltd.
Communications Department
Tokyo, Japan
Tel. +81/ 3-6417-2145

Media contact
Boehringer Ingelheim
Corporate Communications
Judith von Gordon
Binger Strasse 173
55216 Ingelheim am Rhein
GERMANY
Phone +49/6132/77 35 82
Fax +49/6132/77 66 01

   
Record changed: 2019-06-09

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for Boehringer Ingelheim (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px




» top